Steve E. Kalloger

Steve E. Kalloger

University of British Columbia
在 mail.ubc.ca 的电子邮件经过验证
被引用次数：28626
HEOR shared decision making health policy statistical modeling HRQoL
David Waterhouse

David Waterhouse

OHC, Cincinnati OH
在 usoncology.com 的电子邮件经过验证
被引用次数：20984
Lung cancer HEOR GU tumors
Nora Janjan

Nora Janjan

CMO, STATinMED Research
在 statinmed.com 的电子邮件经过验证
被引用次数：20488
HEOR
Ambrish Singh

Ambrish Singh

Doctor of Philosophy (Medical Studies), Hobart, Australia
在 utas.edu.au 的电子邮件经过验证
被引用次数：20133
Systematic Review HEOR Real World Evidence Meta-Analysis Pharmacoepidemiology
Joseph E. Bauer, PhD.

Joseph E. Bauer, PhD.

Levine Cancer Institute, Atrium Health
在 atriumhealth.org 的电子邮件经过验证
被引用次数：18716
Oncology Research Cancer Control HEOR Evaluation Methods(Design/ Testing/ Biostatistics)
Finn Boerlum Børlum Kristensen

Finn Boerlum Børlum Kristensen

Professor of Health Economics and HTA, University of Southern Denmark
在 dadlnet.dk 的电子邮件经过验证
被引用次数：4269
HTA HEOR Market Access
Turgay Ayer

Turgay Ayer

Professor of Industrial and Systems Engineering, Georgia Tech
在 isye.gatech.edu 的电子邮件经过验证
被引用次数：4257
Healthcare Analytics Health Technology Assessment HEOR Real-World Evidence Machine Learning
Ahmed M. Soliman, MS, PhD

Ahmed M. Soliman, MS, PhD

Director, Health Economics and Outcomes Research, AbbVie Inc.
在 abbvie.com 的电子邮件经过验证
被引用次数：4160
Pharmacoeconomics Health Outcomes Research Patient Reported Outcomes HEOR
Dingwei Dai, MD, PhD

Dingwei Dai, MD, PhD

Principal Data Scientist, CVS Health
在 cvshealth.com 的电子邮件经过验证
被引用次数：4056
RWE HEOR Epidemiology Pragmatic Trials Data Science
Wenhui Wei

Wenhui Wei

Regeneron Pharmaceutical Inc.
在 regeneron.com 的电子邮件经过验证
被引用次数：3269
HEOR
1 - 10